SVA Life Sciences is proud to introduce Chuck Howe as a member of our panel of experts. SVA Life Sciences is a division of SVA Consulting that serves leaders in emerging and high growth biopharma, and our panel of experts is a group of seasoned industry leaders whom we know and trust. This panel functions as a resource and sounding board for executives and functional leaders, cultivating high quality work that is aligned with our philosophy of doing right by our clients. We are excited to have Chuck engaged to serve our clients in this capacity.
Chuck brings over 30 years of experience in the Life Sciences industry to SVA Consulting. His expertise is focused in commercialization oversight for emerging biopharma companies, including many aspects of commercial operations design and implementation, field team development and training, fostering improvement in commercial systems and processes, developing strategies for the marketplace and implementing requisite systems to achieve a successful commercial enterprise.
Chuck was responsible for building and leading the Commercial Team that launched Rituxan, the first monoclonal antibody approved for Cancer treatment and the first Oncology therapeutic to reach $1B in annual sales.
Chuck has significant experience leading biopharmaceutical field teams through training and development and most recently served as Executive Director, Operations for an emerging biopharma company commercializing a drug candidate for chronic kidney disease.
Areas of Expertise
Commercial Operations
Training
Sales
Industries:
Life Sciences
Healthcare
Education:
Shorter College
BA, Biology/Chemistry
